115 related articles for article (PubMed ID: 31729719)
21. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
22. Multidrug resistant tuberculosis in a 6 year old child.
Suessmuth S; Bange FC; Gappa M
Paediatr Respir Rev; 2007 Sep; 8(3):265-8. PubMed ID: 17868926
[TBL] [Abstract][Full Text] [Related]
23. Treatment outcomes of multidrug-resistant tuberculosis in Switzerland.
Helbling P; Altpeter E; Egger JM; Zellweger JP
Swiss Med Wkly; 2014; 144():w14053. PubMed ID: 25474040
[TBL] [Abstract][Full Text] [Related]
24. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
[TBL] [Abstract][Full Text] [Related]
25. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
[TBL] [Abstract][Full Text] [Related]
26. Multidrug-resistant tuberculosis in Rawalpindi, Pakistan.
Khurram M; Khaar HT; Fahim M
J Infect Dev Ctries; 2012 Jan; 6(1):29-32. PubMed ID: 22240425
[TBL] [Abstract][Full Text] [Related]
27. Drug resistance in patients with tuberculous pleural effusions.
Skouras VS; Kalomenidis I
Curr Opin Pulm Med; 2018 Jul; 24(4):374-379. PubMed ID: 29528853
[TBL] [Abstract][Full Text] [Related]
28. Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study.
van Kampen SC; Susanto NH; Simon S; Astiti SD; Chandra R; Burhan E; Farid MN; Chittenden K; Mustikawati DE; Alisjahbana B
PLoS One; 2015; 10(6):e0123536. PubMed ID: 26075722
[TBL] [Abstract][Full Text] [Related]
29. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
30. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis.
Teixeira L; Perkins MD; Johnson JL; Keller R; Palaci M; do Valle Dettoni V; Canedo Rocha LM; Debanne S; Talbot E; Dietze R
Int J Tuberc Lung Dis; 2001 Apr; 5(4):321-8. PubMed ID: 11334250
[TBL] [Abstract][Full Text] [Related]
31. Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series.
Judge D; Krause V
Commun Dis Intell Q Rep; 2016 Sep; 40(3):E334-E339. PubMed ID: 28278406
[TBL] [Abstract][Full Text] [Related]
32. Tuberculous empyema.
Bai KJ; Wu IH; Yu MC; Chiang IH; Chiang CY; Lin TP; Lee YC; Luh KT
Respirology; 1998 Dec; 3(4):261-6. PubMed ID: 10201053
[TBL] [Abstract][Full Text] [Related]
33. Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.
van Kampen SC; Tursynbayeva A; Koptleuova A; Murzakhmetova Z; Bigalieva L; Aubakirova M; Pak S; van den Hof S
PLoS One; 2015; 10(7):e0132514. PubMed ID: 26181578
[TBL] [Abstract][Full Text] [Related]
34. Drug susceptibility pattern of Mycobacterium tuberculosis isolates from patients of category-II failure of pulmonary tuberculosis under directly observed treatment short-course from north India.
Prasad R; Verma SK; Garg R; Jain A; Anand SC; Hosmane GB; Verma RK; Kushwaha NS; Kant S
Biosci Trends; 2012 Jun; 6(3):110-4. PubMed ID: 22890158
[TBL] [Abstract][Full Text] [Related]
35. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
Skenders GK; Holtz TH; Riekstina V; Leimane V
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1546-52, i. PubMed ID: 22008771
[TBL] [Abstract][Full Text] [Related]
36. Multidrug-resistant tuberculosis in South Korea: a retrospective analysis of national registry data in 2011-2015.
Lee M; Han J; Kim YR; Kwak N; Kim JH; Park O; Shin S; Moon HS; Kim HJ; Jang MJ; Yim JJ
Int J Tuberc Lung Dis; 2019 Jul; 23(7):850-857. PubMed ID: 31439118
[No Abstract] [Full Text] [Related]
37. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
[TBL] [Abstract][Full Text] [Related]
38. Effect of reliance on Xpert MTB/RIF on time to treatment and multidrug-resistant tuberculosis treatment outcomes in Tanzania: a retrospective cohort study.
Mollel E; Lekule I; Lynen L; Decroo T
Int Health; 2019 Nov; 11(6):520-527. PubMed ID: 30806660
[TBL] [Abstract][Full Text] [Related]
39. [Pleural and parenchymal lung diseases from asbestos exposure. CT diagnosis].
Polverosi R; Vigo M; Citton O
Radiol Med; 2000 Nov; 100(5):326-31. PubMed ID: 11213409
[TBL] [Abstract][Full Text] [Related]
40. [Retrosternal lymphotropic chemotherapy and pneumoperitoneum in the treatment of drug-resistant destructive pulmonary tuberculosis].
Kibrik BS; Zakharov AV; Lobanovskiĭ VM
Probl Tuberk Bolezn Legk; 2009; (5):21-6. PubMed ID: 19565808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
